β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling

Background: Alzheimer's disease (AD), is a progressive neurodegenerative disease that is characterized by cognitive loss. Most researchers believe that aggregation and accumulation of β-amyloid peptides (Aβ) in brain cells are the central pathological hallmark of this disease. Methods: Based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Weiying, Sun, Fengxian, Wan, Moxin, Jiang, Fang, Bo, Xiangyu, Lin, Laixiang, Tang, Hua, Xu, Shumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766670/
https://www.ncbi.nlm.nih.gov/pubmed/29358920
http://dx.doi.org/10.3389/fphar.2017.00969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766670/
https://www.ncbi.nlm.nih.gov/pubmed/29358920
http://dx.doi.org/10.3389/fphar.2017.00969

Ejemplares similares